DK0770876T3 - En screening-fremgangsmåde til at identificere ligander for målproteiner - Google Patents

En screening-fremgangsmåde til at identificere ligander for målproteiner

Info

Publication number
DK0770876T3
DK0770876T3 DK96610042T DK96610042T DK0770876T3 DK 0770876 T3 DK0770876 T3 DK 0770876T3 DK 96610042 T DK96610042 T DK 96610042T DK 96610042 T DK96610042 T DK 96610042T DK 0770876 T3 DK0770876 T3 DK 0770876T3
Authority
DK
Denmark
Prior art keywords
target proteins
target protein
ligands
screening method
identifying ligands
Prior art date
Application number
DK96610042T
Other languages
Danish (da)
English (en)
Inventor
Andrew Pakula
James Bowie
Original Assignee
Anadys Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anadys Pharmaceuticals Inc filed Critical Anadys Pharmaceuticals Inc
Application granted granted Critical
Publication of DK0770876T3 publication Critical patent/DK0770876T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96610042T 1995-10-25 1996-10-17 En screening-fremgangsmåde til at identificere ligander for målproteiner DK0770876T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54788995A 1995-10-25 1995-10-25

Publications (1)

Publication Number Publication Date
DK0770876T3 true DK0770876T3 (da) 2001-08-06

Family

ID=24186560

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96610042T DK0770876T3 (da) 1995-10-25 1996-10-17 En screening-fremgangsmåde til at identificere ligander for målproteiner

Country Status (14)

Country Link
EP (1) EP0770876B1 (de)
JP (1) JP2952848B2 (de)
KR (1) KR0161256B1 (de)
AT (1) ATE200579T1 (de)
AU (1) AU698862B2 (de)
BR (1) BR9604352A (de)
CA (1) CA2184195C (de)
DE (2) DE69612457T2 (de)
DK (1) DK0770876T3 (de)
ES (1) ES2158269T3 (de)
GR (1) GR3036138T3 (de)
IL (1) IL119149A (de)
MX (1) MX9604183A (de)
PT (1) PT770876E (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU741049B2 (en) * 1996-05-09 2001-11-22 Life Technologies Corporation Microplate thermal shift assay and apparatus for ligand development and multi-variable protein chemistry optimization
US6453246B1 (en) 1996-11-04 2002-09-17 3-Dimensional Pharmaceuticals, Inc. System, method, and computer program product for representing proximity data in a multi-dimensional space
US6571227B1 (en) 1996-11-04 2003-05-27 3-Dimensional Pharmaceuticals, Inc. Method, system and computer program product for non-linear mapping of multi-dimensional data
CA2269669A1 (en) 1996-11-04 1998-05-14 3-Dimensional Pharmaceuticals, Inc. System, method and computer program product for identifying chemical compounds having desired properties
PL194483B1 (pl) 1997-11-12 2007-06-29 Dimensional Pharmaceuticals 3 Sposób wyznaczania funkcji biologicznej docelowego białka
US6569631B1 (en) 1998-11-12 2003-05-27 3-Dimensional Pharmaceuticals, Inc. Microplate thermal shift assay for ligand development using 5-(4″dimethylaminophenyl)-2-(4′-phenyl)oxazole derivative fluorescent dyes
GB9904395D0 (en) * 1999-02-25 1999-04-21 Fluorescience Ltd Protein assay
US6972198B2 (en) * 1999-02-26 2005-12-06 Cyclacel, Ltd. Methods and compositions using protein binding partners
JP4493125B2 (ja) 1999-05-07 2010-06-30 独立行政法人理化学研究所 相互作用するタンパク質の検出方法
US6582907B1 (en) * 1999-12-09 2003-06-24 Pharmacia & Upjohn Company Use of fluorescence correlation spectroscopy to identify compounds that bind to target species under isothermal denaturing conditions
US6376180B1 (en) 1999-12-09 2002-04-23 Pharmacia & Upjohn Company Methods of identifying compounds that bind to target species under isothermal denaturing conditions
US7416524B1 (en) 2000-02-18 2008-08-26 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. System, method and computer program product for fast and efficient searching of large chemical libraries
AU2001241800A1 (en) 2000-02-29 2001-09-12 3-Dimensional Pharmaceuticals, Inc. Method and computer program product for designing combinatorial arrays
AU2001247627A1 (en) 2000-03-22 2001-10-03 3-Dimensional Pharmaceuticals, Inc. System, method, and computer program product for representing object relationships in a multidimensional space
WO2001075790A2 (en) 2000-04-03 2001-10-11 3-Dimensional Pharmaceuticals, Inc. Method, system, and computer program product for representing object relationships in a multidimensional space
KR20010112840A (ko) * 2000-06-15 2001-12-22 김유삼 기능성 단백질의 패턴분석을 이용한 진단 시스템
US7054757B2 (en) 2001-01-29 2006-05-30 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Method, system, and computer program product for analyzing combinatorial libraries
JPWO2003020960A1 (ja) * 2001-09-03 2004-12-16 協和醗酵工業株式会社 薬物の標的蛋白質を決定する方法
WO2003023360A2 (en) 2001-09-10 2003-03-20 Meso Scale Technologies, Llc Methods and apparatus for conducting multiple measurements on a sample
CA2601869A1 (en) 2005-08-12 2007-02-22 Astellas Pharma Inc. Method for identifying target protein of agent and method for screening therapeutic agent for diabetes using target protein
DE102006027259A1 (de) * 2006-06-09 2007-12-13 Protagen Ag Protein-Biochip zum differentiellen Screenen von Protein-Protein-Wechselwirkungen
US11492340B2 (en) 2017-02-15 2022-11-08 Ohio State Innovation Foundation Heteroaromatic electrophiles and methods of using thereof
CN114076826A (zh) * 2020-08-20 2022-02-22 中国科学院大连化学物理研究所 一种微球辅助的基于蛋白加热沉淀的药物靶蛋白筛选方法
GB202118173D0 (en) * 2021-12-15 2022-01-26 Medicines Discovery Catpult Ltd Protein stability assay

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231755B2 (de) * 1973-01-08 1977-08-17
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
WO1992003542A1 (en) * 1990-08-17 1992-03-05 Boston University PROTEASES CAUSING ABNORMAL DEGRADATION OF AMYLOID β-PROTEIN PRECURSOR
US5506097A (en) * 1990-08-24 1996-04-09 President And Fellows Of Harvard College Method for inhibiting β-protein enzymatic activity
WO1993014781A1 (en) * 1992-01-24 1993-08-05 The Regents Of The University Of California Novel peptides and method for altering the activity of allosteric proteins
CA2115900A1 (en) * 1993-02-22 1994-08-23 Gerald W. Becker Pharmaceutical screens and antibodies
US5585277A (en) * 1993-06-21 1996-12-17 Scriptgen Pharmaceuticals, Inc. Screening method for identifying ligands for target proteins
JP2000502440A (ja) 1995-12-07 2000-02-29 スクリプトジェン・ファーマスーティカルズ,インコーポレイテッド リガンドを識別するための蛍光に基づくスクリーニング方法
WO1997020925A1 (en) * 1995-12-08 1997-06-12 Hybridon, Inc. Modified vegf antisense oligonucleotides for treatment of skin disorders
AU741049B2 (en) * 1996-05-09 2001-11-22 Life Technologies Corporation Microplate thermal shift assay and apparatus for ligand development and multi-variable protein chemistry optimization
US8082993B2 (en) 2009-03-12 2011-12-27 Halliburton Energy Services, Inc. One trip gravel pack assembly

Also Published As

Publication number Publication date
EP0770876A1 (de) 1997-05-02
DE69612457D1 (de) 2001-05-17
EP0770876B1 (de) 2001-04-11
IL119149A (en) 2002-03-10
ES2158269T3 (es) 2001-09-01
AU6429896A (en) 1997-05-01
KR0161256B1 (ko) 1999-03-30
JP2952848B2 (ja) 1999-09-27
GR3036138T3 (en) 2001-09-28
AU698862B2 (en) 1998-11-12
DE69612457T2 (de) 2001-11-08
MX9604183A (es) 1998-04-30
JPH09178746A (ja) 1997-07-11
IL119149A0 (en) 1996-11-14
BR9604352A (pt) 1998-06-16
DE770876T1 (de) 1999-07-22
PT770876E (pt) 2001-09-28
CA2184195C (en) 2002-04-16
ATE200579T1 (de) 2001-04-15
CA2184195A1 (en) 1997-04-26
KR970022315A (ko) 1997-05-28

Similar Documents

Publication Publication Date Title
DK0770876T3 (da) En screening-fremgangsmåde til at identificere ligander for målproteiner
ATE376187T1 (de) Nachweis von erkrankungen der nieren und behandlung
DE69632447D1 (de) Analysator zur Analyse von Urinbestandteilen
FI915150A7 (fi) Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi
DE69612017D1 (de) Emulsion zur robusten erfassung von gasen
DE69638248D1 (de) Nachweis von DNS-Sequenz Variationen
DE3872754D1 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
DE68929334D1 (de) Verfahren zumm Assay von Endotoxin-Konzentration
DE69622978D1 (de) Analysator zur Analyse von Urinbestandteilen
DE69312185D1 (de) Chromatographischer Sandwichtest zur Bestimmung von spezifischen Antikörpern und Vorrichtung hierfür
ATE397215T1 (de) Entstörung von immunoassays durch substanzen, die aus den framework-regionen von antikörpern abgeleitet sind
FI895215A7 (fi) Menetelmä antitrombiini III:n biologisen aktiivisuuden määrittämiseksi ja reagenssi sitä varten
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
ATE105086T1 (de) Diagnostisches mittel und verfahren zur bestimmung von apolipoprotein b.
FI854627A7 (fi) Menetelmä ja reagenssi plasmassa, seerumissa tai kokoveressä olevan vapaan tyroksiinin kvantitatiiviseksi määrittämiseksi.
FI910324A7 (fi) Menetelmät ja testipakkaukset ihmisen leukosyyttiantigeeni-DNA:n havaitsemiseksi
DE69007155D1 (de) Automatisierte Schnittentwicklungsanalyse von mehrfachen Proben.
DK0445626T3 (da) Funktionel test til bestemmelse af protein S-aktivitet.
RU94021664A (ru) Способ идентификации и количественного определения вредных побочных продуктов сульфирования методом ионной хроматографии
FI913417A0 (fi) Anordning vid vattensaeng.
DE59008687D1 (de) Verfahren zur selektiven komplexometrischen quantitativen Bestimmung von N-(Phosphonomethyl)-glycin-(glifosat(R)) und Derivat davon.
FI893333A0 (fi) Menetelmä ja reagenssi vasta-aineiden määrittämiseksi
ATE171545T1 (de) Verfahren zur bestimmung des lysingehaltes von samen
DE69020496D1 (de) Vermessung von Diaphoraseaktivität und Reagenz dazu.
IT8921587A0 (it) Metodo di analisi gas cromatografica di miscele di sostanze e dispositivo per la sua realizzazione.